Alterations in peripheral T- and B-cell subsets in patients with systemic sclerosis

Int J Rheum Dis. 2024 Apr;27(4):e15145. doi: 10.1111/1756-185X.15145.

Abstract

Objectives: To determine the alteration of peripheral T and B cell subsets in patients with systemic sclerosis (SSc) and to evaluate their correlation with the progression of SSc.

Methods: We recruited 47 SSc patients and 45 healthy controls (HCs) in this study. Demographic and clinical data were then collected. Flow cytometry was used to detect the proportions of 44 different T and B cell subsets in circulating blood.

Results: The proportion of total B cells (p = .043) decreased in SSc patients, together with similar frequencies of total T cells, CD4+ T cells, and CD8+ T cells in both groups. Several subsets of T and B cells differed significantly between these two groups. Follicular helper T cells-1 (Tfh1) (p < .001), helper T cells-1 (Th1) (p = .001), regulatory T cells (Treg) (p = .004), effector memory CD8+ T cells (p = .041), and cytotoxic T cells-17 (Tc17) (p = .01) were decreased in SSc patients. Follicular helper T cells-2 (Tfh2) (p = .001) and, helper T cells-2 (Th2) (p = .001) levels increased in the SSc group. Regulatory B cells (Breg) (p = .015) were lower in the SSc group, together with marginal zone (MZ) B cells (p < .001), memory B cells (p = .001), and non-switched B cells (p = .005). The modified Rodnan skin score (mRSS) correlated with helper T cells-17 (Th17) (r = -.410, p = .004), Tfh1 (r = -.321, p = .028), peripheral helper T cells (Tph) (r = -.364, p = .012) and plasma cells (r = -.312, p = .033).

Conclusions: The alterations in T and B cells implied immune dysfunction, which may play an essential role in systemic sclerosis.

Keywords: B cell; T cell; alterations; flow cytometry; systemic sclerosis.

MeSH terms

  • Adult
  • Aged
  • B-Lymphocyte Subsets* / immunology
  • Case-Control Studies
  • Disease Progression
  • Female
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Male
  • Middle Aged
  • Phenotype
  • Scleroderma, Systemic* / blood
  • Scleroderma, Systemic* / diagnosis
  • Scleroderma, Systemic* / immunology
  • T-Lymphocyte Subsets / immunology